文献速递主动脉疾病外周动脉疾病

光纤实时三维导航(FORS)首次人体临床可行性研究

First in Human Clinical Feasibility Study of Endovascular Navigation with Fiber Optic RealShape (FORS) Technology.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-11-29

21例手术无器械或技术相关并发症,66项导航任务中60项(90.9%)使用至少一种FORS器械获得技术成功;使用者评价16/21例优于标准引导、5/21例与标准引导相当,透视时间0.0至52.2分钟。结论认为FORS在腹部和外周血管腔内手术中安全可行,但需对照研究评估获益与辐射减少。

要点

  • FORS作为传统透视的附加技术,可实时三维显示腔内器械。
  • 66项导航任务中90.9%使用FORS器械获得技术成功。
  • 21例手术无器械或技术相关并发症,部分任务无需或仅需极少X线。

核心结论

  • FORS实时导航在腹部和外周血管腔内手术中安全可行,并可能改善术中影像引导。

主要发现

  • 因启动时技术问题,1例EVAR未能使用FORS系统;其余21例手术无器械或技术相关并发症,共涉及66项导航任务。
  • 66项导航任务中60项(90.9%)使用至少一种FORS器械获得技术成功。
  • 使用者评价FORS图像引导在16/21例中「优于标准引导」、在5/21例中「与标准引导相当」。
  • 透视时间范围为0.0至52.2分钟,部分任务无需或仅需极少X线完成。

临床怎么用

  • 在EVAR和EVPLR的导航任务(如目标血管插管或跨越狭窄病变)中,可选用FORS兼容的柔性导丝、Cobra-2导管或Berenstein导管。
  • FORS可作为传统透视的附加引导手段,器械选择由医生酌情决定,可组合FORS与非FORS器械。

局限性

  • 本研究为首次人体可行性研究,样本量小(22例),未设对照组。
  • 原文指出需开展对照研究以评估FORS的获益及潜在辐射减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular procedures are conventionally conducted using two dimensional fluoroscopy. A new technology platform, Fiber Optic RealShape (FORS), has recently been introduced allowing real time, three dimensional visualisation of endovascular devices using fiberoptic technology. It functions as an add on to conventional fluoroscopy and may facilitate endovascular procedures. This first in human study assessed the feasibility of FORS in clinical practice. METHODS: A prospective cohort feasibility study was performed between July and December 2018. Patients undergoing (regular or complex) endovascular aortic repair (EVAR) or endovascular peripheral lesion repair (EVPLR) were recruited. FORS guidance was used exclusively during navigational tasks such as target vessel catheterisation or crossing of stenotic lesions. Three types of FORS enabled devices were available: a flexible guidewire, a Cobra-2 catheter, and a Berenstein catheter. Devices were chosen at the physician's discretion and could comprise any combination of FORS and non-FORS devices. The primary study endpoint was technical success of the navigational tasks using FORS enabled devices. Secondary study endpoints were user experience and fluoroscopy time. RESULTS: The study enrolled 22 patients: 14 EVAR and eight EVPLR patients. Owing to a technical issue during start up, the FORS system could not be used in one EVAR. The remaining 21 procedures proceeded without device or technology related complications and involved 66 navigational tasks. In 60 tasks (90.9%), technical success was achieved using at least one FORS enabled device. Users rated FORS based image guidance "better than standard guidance" in 16 of 21 and "equal to standard guidance" in five of 21 procedures. Fluoroscopy time ranged from 0.0 to 52.2 min. Several tasks were completed without or with only minimal X-ray use. CONCLUSION: Real time navigation using FORS technology is safe and feasible in abdominal and peripheral endovascular procedures. FORS has the potential to improve intra-operative image guidance. Comparative studies are needed to assess these benefits and potential radiation reduction.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. van Herwaarden JA, Jansen MM, Vonken EPA, et al. First in Human Clinical Feasibility Study of Endovascular Navigation with Fiber Optic RealShape (FORS) Technology. Eur J Vasc Endovasc Surg. 2020. PMID: 33262088. doi:10.1016/j.ejvs.2020.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。